Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009

• Press Release
• Source: Endologix, Inc.
• On 9:00 am EDT, Friday October 16, 2009

IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX - News), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its third quarter 2009 financial results, which will take place on Tuesday, October 27, 2009 after the close of the market.

Endologix will hold a conference call on Tuesday, October 27, 2009 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for domestic callers and (201) 689-8562 for international callers. A live Web cast of the conference call will be available online from the investor relations page of the Company's corporate website at www.endologix.com.

After the live Web cast, the call will remain available on Endologix's Web site, www.endologix.com, through November 27, 2009. In addition, a telephonic replay of the call will be available until November 3, 2009. The replay dial-in numbers are (877) 660-6853 for domestic callers and (201) 612-7415 for international callers. Please use account number 3055 and conference ID number 335438.

About Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.

    COMPANY CONTACT:                   INVESTOR CONTACTS:
    Endologix, Inc.                    The Ruth Group
    John McDermott, CEO                Nick Laudico (646) 536-7030
    (949) 595-7200                     Zack Kubow (646) 536-7020
    www.endologix.com

Buzz up!